Compare ICU & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ICU | FOFO |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3M | 15.8M |
| IPO Year | 2021 | 2025 |
| Metric | ICU | FOFO |
|---|---|---|
| Price | $2.21 | $1.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 220.8K | 25.5K |
| Earning Date | 11-12-2026 | 12-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,234,000.00 | N/A |
| Revenue This Year | $62.07 | N/A |
| Revenue Next Year | $46.55 | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | ★ 814.07 | N/A |
| 52 Week Low | $0.22 | $1.70 |
| 52 Week High | $5.38 | $14.93 |
| Indicator | ICU | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 33.81 | 37.28 |
| Support Level | N/A | $1.76 |
| Resistance Level | $2.82 | $2.68 |
| Average True Range (ATR) | 0.30 | 0.12 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 1.12 | 0.00 |
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their business and investment objectives. Its business consists of two main business lines: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting and Regulatory compliance and governance consulting, and the asset management services, including fund subscription and fund management services.